Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Antibody Design Labs is a biotechnology company specializing in advanced tools and services for antibody discovery and engineering. The company provides a comprehensive suite of phage display technologies, including specialized phagemid vectors, helper phages, and high-efficiency competent cells. Their proprietary TGEX (Transient Gene Expression) platform enables the rapid and high-yield production of recombinant antibodies in mammalian cells. Beyond their product catalog, they offer contract research services such as custom phage display library construction, antibody humanization, and affinity maturation. Antibody Design Labs supports a global clientele ranging from academic laboratories to major biopharmaceutical companies in their quest to develop novel therapeutic and diagnostic antibodies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antibody Design Labs.